+343.0%
MRNA vs LII
-30.1%
+373.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | LII | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +1.1% | -4.6% | -4.0% |
| 7D | -12.1% | +2.9% | -15.1% | -13.4% |
| 30D | -1.3% | +0.9% | -2.2% | -3.2% |
| 3M | +250.9% | -15.5% | +266.5% | +288.5% |
| 6M | +343.0% | -30.2% | +373.2% | +382.3% |
| All | +343.0% | -30.1% | +373.1% | +382.3% |
Cumulative growth
Daily Returns
Daily percentage return beside LII.
Daily Out/Under-Performance
Portfolio return minus LII return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LII return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded LII wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling